The AMRIT initiative, operated on a COCO model by HLL Lifecare Limited, has introduced a suite of measures to ensure efficiency, transparency and quality in its pharmacy network.
Key Developments
- Annual statutory audits of financial and operational performance.
- Deployment of an integrated IT system for automatic discount application.
- Direct procurement of branded medicines from reputable manufacturers or authorised distributors to guarantee authenticity.
- Activation of a robust public grievance mechanism via hospital authorities, dedicated email, HLL website and the CPGRAMS portal.
- Implementation of pricing and discount structures as per the MoU between HLL Lifecare and state/host institutions.
Important Facts
The scheme targets patients with high‑cost ailments such as cancer and cardiovascular diseases, aiming to reduce out‑of‑pocket expenditure. Under the COCO model, HLL Lifecare owns the pharmacy premises and manages day‑to‑day operations, ensuring uniformity across states. The annual audits and IT‑driven discounting minimize scope for manual manipulation, while direct sourcing eliminates middle‑men, curbing counterfeit risks.
UPSC Relevance
Understanding AMRIT is crucial for GS1 (Health & Social Justice) as it illustrates government intervention to improve access to essential medicines. The role of